74 related articles for article (PubMed ID: 3540513)
1. [Clonogenic capacity and proliferative activity of the cells of malignant tumors of the bones].
Kolesnikova AI; Konopliannikov AG; Bizer VA; Semichastnova LM; Lepekhina LA
Med Radiol (Mosk); 1986 Dec; 31(12):36-40. PubMed ID: 3540513
[TBL] [Abstract][Full Text] [Related]
2. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
[TBL] [Abstract][Full Text] [Related]
3. [Androgen metabolism in malignant and benign bone tumors].
Kushlinskiĭ NE; Degtiar' VG; Babkina TV; Solov'ev IuN; Aliev MD; Trapeznikov NN
Biull Eksp Biol Med; 2000 Jan; 129(1):90-2. PubMed ID: 10710639
[No Abstract] [Full Text] [Related]
4. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
8. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
9. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases.
Machado I; Alberghini M; Giner F; Corrigan M; O'Sullivan M; Noguera R; Pellin A; Bertoni F; Llombart-Bosch A
Histopathology; 2010 Jul; 57(1):162-7. PubMed ID: 20557371
[No Abstract] [Full Text] [Related]
11. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
12. Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
Beccheroni A; Lucarelli E; Donati D; Sangiorgi L; Capponcelli S; Gorini M; Zambon Bertoja A; Giardino R; Mercuri M; Ferrari S; Bacci G; Picci P
Oncol Rep; 2003; 10(4):891-6. PubMed ID: 12792741
[TBL] [Abstract][Full Text] [Related]
13. Aspiration biopsy cytology of primary bone lesions.
Kumar RV; Rao CR; Hazarika D; Mukherjee G; Gowda BM
Acta Cytol; 1993; 37(1):83-9. PubMed ID: 8434500
[TBL] [Abstract][Full Text] [Related]
14. Round cell tumours of bone.
Roessner A; Jürgens H
Pathol Res Pract; 1993 Dec; 189(10):111-36. PubMed ID: 8183732
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
16. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
18. Sarcomas of bone in childhood: pathologic aspects.
Kissane JM; Askin FB; Nesbit ME; Vietti TJ; Burgert EO; Cangir A; Gehan EA; Perez CA; Pritchard DJ; Tefft M
Natl Cancer Inst Monogr; 1981 Apr; (56):29-41. PubMed ID: 6272116
[TBL] [Abstract][Full Text] [Related]
19. Procollagens as markers for the cell of origin of human bone tumors.
Stern R; Wilczek J; Thorpe WP; Rosenberg SA; Cannon G
Cancer Res; 1980 Feb; 40(2):325-8. PubMed ID: 6927962
[TBL] [Abstract][Full Text] [Related]
20. Bone-forming tumors of the upper extremity and Ewing's sarcoma.
Sforzo CR; Scarborough MT; Wright TW
Hand Clin; 2004 Aug; 20(3):303-15, vi. PubMed ID: 15275689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
